Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenues    
Products $ 476 $ 9,448
Services 1,619 4,033
Total Revenues 2,095 13,481
Cost of Revenues    
Products 255 8,054
Services 604 2,139
Total Cost of Revenues 859 10,193
Gross Profit 1,236 3,288
Operating Expenses    
Research and development 361 558
Sales and marketing 969 2,040
General and administrative 4,174 4,658
Acquisition related costs 16 3
Amortization of intangibles 1,323 1,383
Total Operating Expenses 6,843 8,642
Loss from Operations (5,607) (5,354)
Other Income (Expense)    
Interest expense (1,283) (684)
Change in fair value of derivative liability 48 56
Gain on the sale of Sysorex Arabia 23
Other income/(expense) 576 (65)
Total Other Income (Expense) (636) (693)
Net Loss from Continuing Operations (6,243) (6,047)
Loss from Discontinued Operations, Net of Tax (9)
Net Loss (6,243) (6,056)
Net Loss Attributable to Non-controlling Interest (4)
Net Loss Attributable to Stockholders of Inpixon (6,243) (6,052)
Deemed dividend to preferred stockholders (1,508)
Net Loss Attributable to Common Stockholders $ (7,751) $ (6,052)
Net Loss Per Basic and Diluted Common Share    
Loss from continuing operations $ (1.85) $ (83.56)
Loss from discontinued operations (0.12)
Net Loss Per Share - Basic and Diluted $ (1.85) $ (83.63)
Weighted Average Shares Outstanding    
Basic and Diluted 4,196,612 72,364